Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Intangibles: 2020-2024

Historic Intangibles for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $195.0 million.

  • Maravai Lifesciences Holdings' Intangibles fell 7.92% to $185.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.9 million, marking a year-over-year decrease of 7.92%. This contributed to the annual value of $195.0 million for FY2024, which is 11.78% down from last year.
  • According to the latest figures from FY2024, Maravai Lifesciences Holdings' Intangibles is $195.0 million, which was down 11.78% from $221.0 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Intangibles registered a high of $221.0 million during FY2023, and its lowest value of $117.6 million during FY2021.
  • Moreover, its 3-year median value for Intangibles was $216.7 million (2022), whereas its average is $210.9 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Intangibles plummeted by 33.82% in 2021, and later soared by 84.28% in 2022.
  • Yearly analysis of 5 years shows Maravai Lifesciences Holdings' Intangibles stood at $177.7 million in 2020, then slumped by 33.82% to $117.6 million in 2021, then spiked by 84.28% to $216.7 million in 2022, then grew by 2.00% to $221.0 million in 2023, then dropped by 11.78% to $195.0 million in 2024.